Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Clin Immunol ; 258: 109870, 2024 01.
Artigo em Inglês | MEDLINE | ID: mdl-38101497

RESUMO

Recent studies have highlighted the important role of B cells in the pathogenesis of multiple sclerosis (MS). B cell activating factor (BAFF) and A proliferation inducing ligand (APRIL) play a major role in B cell survival and homeostasis. Here, we studied the association of BAFF and APRIL with B cell immune markers in MS and following B cell depletion and repopulation. We found that BAFF but not APRIL was significantly higher in plasma in untreated MS compared to controls. BAFF increased after rituximab treatment and decreased again during repopulation displaying an inverse correlation with B cell numbers, and more specifically switched memory B cell numbers. Cerebrospinal fluid BAFF inversely correlated with IgG index. BAFF displayed an inverse association to anti-EBV-CA antibodies. In summary, our study identified immune cells and factors that might regulate or be regulated by BAFF and APRIL levels in MS, and during B cell depletion and repopulation.


Assuntos
Esclerose Múltipla , Humanos , Fator Ativador de Células B , Membro 13 da Superfamília de Ligantes de Fatores de Necrose Tumoral , Rituximab/uso terapêutico , Linfócitos B/patologia , Interleucina-4
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA